RNSterápia

RNSterápia, also known as Responsive Neurostimulation, is a medical treatment device used for managing refractory epilepsy, a condition where seizures are not adequately controlled by medication. It is an implantable device that continuously monitors brain activity for abnormal patterns indicative of an impending seizure. When such patterns are detected, the RNS system delivers small electrical impulses to the brain to interrupt the seizure before it can fully develop or spread.

The RNS system consists of a small neurostimulator implanted in the skull and one or two leads, which are wires with electrodes, placed in specific areas of the brain known to be the origin of seizures. These leads detect abnormal electrical activity, and the neurostimulator analyzes this data and responds with stimulation as programmed by the patient's neurologist. The device is designed to be adaptive, learning from the patient's seizure patterns over time to optimize its response.

The primary goal of RNSterápia is to reduce the frequency and severity of seizures in individuals with epilepsy who have not found sufficient relief from anti-seizure medications. It is typically considered for patients who have a clear focus of seizure onset in the brain that can be identified and targeted by the device. The implantation procedure is surgical, and ongoing management involves regular follow-up appointments with a neurologist to adjust the device's settings and monitor its effectiveness and safety. While it does not cure epilepsy, RNSterápia aims to significantly improve a patient's quality of life by reducing seizure burden and allowing for greater independence.